155 related articles for article (PubMed ID: 38055673)
21. MicroRNA‑3666 suppresses the growth and migration of glioblastoma cells by targeting KDM2A.
Shou T; Yang H; Lv J; Liu D; Sun X
Mol Med Rep; 2019 Feb; 19(2):1049-1055. PubMed ID: 30483744
[TBL] [Abstract][Full Text] [Related]
22. A novel lncRNA MDHDH suppresses glioblastoma multiforme by acting as a scaffold for MDH2 and PSMA1 to regulate NAD+ metabolism and autophagy.
He D; Xin T; Pang B; Sun J; Liu ZH; Qin Z; Ji XS; Yang F; Wei YB; Wang ZX; Gao JJ; Pang Q; Liu Q
J Exp Clin Cancer Res; 2022 Dec; 41(1):349. PubMed ID: 36527092
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
24. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of microRNA-129-5p in glioblastoma inhibits cell proliferation, migration, and colony-forming ability by targeting ZFP36L1.
Guo X; Piao H; Zhang Y; Sun P; Yao B
Bosn J Basic Med Sci; 2020 Nov; 20(4):459-470. PubMed ID: 31999936
[TBL] [Abstract][Full Text] [Related]
26. PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway.
Sun J; Xu Y; Liu J; Cui H; Cao H; Ren J
Cancer Sci; 2022 Feb; 113(2):500-516. PubMed ID: 34812552
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
[TBL] [Abstract][Full Text] [Related]
28. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
29. The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2.
Qi J; Pan L; Yu Z; Ni W
Pathol Res Pract; 2021 Jul; 223():153319. PubMed ID: 33991848
[TBL] [Abstract][Full Text] [Related]
30. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
31. Podocalyxin-like protein is expressed in glioblastoma multiforme stem-like cells and is associated with poor outcome.
Binder ZA; Siu IM; Eberhart CG; Ap Rhys C; Bai RY; Staedtke V; Zhang H; Smoll NR; Piantadosi S; Piccirillo SG; Dimeco F; Weingart JD; Vescovi A; Olivi A; Riggins GJ; Gallia GL
PLoS One; 2013; 8(10):e75945. PubMed ID: 24146797
[TBL] [Abstract][Full Text] [Related]
32. Expression and prognostic significance of TCTN1 in human glioblastoma.
Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
[TBL] [Abstract][Full Text] [Related]
33. MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma.
Jarboe JS; Anderson JC; Duarte CW; Mehta T; Nowsheen S; Hicks PH; Whitley AC; Rohrbach TD; McCubrey RO; Chiu S; Burleson TM; Bonner JA; Gillespie GY; Yang ES; Willey CD
Clin Cancer Res; 2012 Jun; 18(11):3030-41. PubMed ID: 22619307
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of NUSAP1 in progression and expansion of glioblastoma multiforme.
Qian Z; Li Y; Ma J; Xue Y; Xi Y; Hong L; Dai X; Zhang Y; Ji X; Chen Y; Sheng M; Sheng Y; Yang L; Liu J; Dai X; Shi J; Xie T; Dong J
J Neurooncol; 2018 Nov; 140(2):199-208. PubMed ID: 29995176
[TBL] [Abstract][Full Text] [Related]
35. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
36. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
37. Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma.
Martins EP; Gonçalves CS; Pojo M; Carvalho R; Ribeiro AS; Miranda-Gonçalves V; Taipa R; Pardal F; Pinto AA; Custódia C; Faria CC; Baltazar F; Sousa N; Paredes J; Costa BM
Mol Oncol; 2022 Jul; 16(14):2611-2631. PubMed ID: 34919784
[TBL] [Abstract][Full Text] [Related]
38. BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression.
Zhao X; Sun Q; Dou C; Chen Q; Liu B
Front Biosci (Landmark Ed); 2019 Mar; 24(6):1060-1070. PubMed ID: 30844730
[TBL] [Abstract][Full Text] [Related]
39. Establishment and validation of an immune-based prognostic score model in glioblastoma.
Qin Z; Zhang X; Chen Z; Liu N
Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of c-Met is Associated with Poor Prognosis in Glioblastoma Multiforme: A Systematic Review and Meta-Analyses.
Anton J; Sudibio S; Handoko H; Permata TBM; Kodrat H; Nuryadi E; Sofyan H; Susanto E; Mulyadi R; Aman RA; Gondhowiardjo S
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3075-3080. PubMed ID: 34710981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
